Positive Blood Culture Identification And Ast Kit
Microbiology · 21 CFR 866.1650
Fluorescence in situ hybridization (FISH) identification and quantitative, antimicrobial susceptibility testing (AST) kit intended for simultaneous detection and identification of multiple microbial targets.
Recent MDR events
4 adverse event reports on file
- ACCELERATE PHENOTEST BC KITApr 26, 2023InjuryAccelerate Diagnostics3010671651-2023-00001
- ACCELERATE PHENO SYSTEM, ACCELERATE PHENOTEST BC KITMar 17, 2020MalfunctionAccelerate Diagnostics, Inc.3010671651-2020-00001
- ACCELERATE PHENO SYSTEMFeb 12, 2020Accelerate Diagnotics9699497
- ACCELERATE PHENO SYSTEM, ACCELERATE PHENOTEST BC KITOct 23, 2019MalfunctionAccelerate Diagnostics, Inc.3010671651-2019-00001
Event type breakdown
Most-reported manufacturers
Recalls
4 recall events for this product code
- Accelerate Diagnostics IncOpen, ClassifiedDec 6, 2022
Accelerate PhenoTest BC kit REF 10101018
Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.
Z-0345-2023 · View FDA record ↗ - Accelerate Diagnostics IncOpen, ClassifiedDec 6, 2022
Accelerate PhenoTest BC kit REF 10102018
Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.
Z-0346-2023 · View FDA record ↗ - Accelerate Diagnostics IncTerminatedUnknown
Accelerate Pheno system, with Accelerate Pheno System Software 1.2.1 - 1.3.1, PSW000012B
Rare isolates of Enterobacteriaceae may generate a susceptible meropenem Minimum Inhibitory Concentration (MIC) using the affected device and a resistant result by broth microdilution. In order to mitigate any risk associated with these rare isolates, the firm has implemented an Expert Rule that suppresses the meropenem result for isolates that display a profile consistent with those that generated a false-susceptible result. The firm has responded to this risk by implementing a set of suppression rules, in a software update, to prevent incorrect results.
Z-1065-2019 · View FDA record ↗ - Accelerate Diagnostics IncTerminatedUnknown
Accelerate PhenoTest BC kit, Ref #10101018. The firm name on the label is Accelerate Diagnostics, Tucson, AZ.
The kits may produce an elevated rate of false positive calls for the Staphylococcus aureus identification probe (SAU).
Z-1529-2018 · View FDA record ↗
Registered firms
0 firms currently registered for this product code
No registered firms found for this product code.